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Pioneering robotic liver surgery in
Germany: first experiences with liver
malignancies
Roland S. Croner*, Aristotelis Perrakis, Maximillian Brunner, Klaus E. Matzel and
Werner Hohenberger
Department of Surgery and Liver Center, University Hospital Erlangen, Erlangen, Germany
Background:Minimally invasive liver surgery is growing worldwide with obvious benefits
for the treated patients. These procedures maybe improved by robotic techniques, which
add several innovative features. In Germany, we were the first surgical department
implementing robotic assisted minimally invasive liver resections.
Material and methods: Between June 2013 and March 2015, we performed robotic
based minimally invasive liver resections in nine patients with malignant liver disease. Five
off these patients suffered from primary and four from secondary liver malignancies. We
retrospectively analyzed the perioperative variables of these patients and the oncological
follow up.
Results: Mean age of the patients was 63 years (range 45–71). One patient suffered
from intrahepatic cholangiocellular, four from hepatocellular carcinoma, and four patients
from colorectal liver metastases. In six patients, left lateral liver resection, in two cases
single segment resection, and in one case minimally invasive guided liver ablation
were performed. Five patients underwent previous abdominal surgery. Mean opera-
tion time was 312min (range 115–458min). Mean weight of the liver specimens was
182g (range 62–260 g) and mean estimated blood loss was 251ml (range 10–650ml).
The mean tumor size was 4.4 cm (range 3.5–5.5 cm). In all cases, R0 status was
confirmed with a mean margin of 0.6 cm (range 0.1–1.5 cm). One patient developed
small bowel fistula on postoperative day 5, which could be treated conservatively. No
patient died. Mean hospital stay of the patients was 6 days (range 3–10days). During
a mean follow up of 12months (range 1–21months), two patients developed tumor
recurrence.
Conclusion: Robotic-based liver surgery is feasible in patients with primary and sec-
ondary liver malignancies. To achieve perioperative parameters comparable to open
settings, the learning curve must be passed. Minor liver resections are good candidates
to start this technique. But the huge benefits of robotic-based liver resections should
be expected in extended procedures beyond minor liver resections with the currently
available technology.
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Introduction
Minimally invasive liver surgery is growing worldwide. Initially
recommended for smaller benign lesions only, recent meta-
analysis demonstrates the value for malignant tumors as well.
No differences in the long-term survival and tumor recurrence
for patients between open and laparoscopic procedures were
observed. But the blood loss and postoperative complication rates
seem to be lower in minimally invasive procedures (1, 2). There-
fore, the laparoscopic left lateral resection was recently recom-
mended as standard of care (3). Currently, techniques for the
minimally invasive access to all liver segments for minor and
major resections are described (4). Robotic-based surgical tech-
niques are currently in the focus of interest and are evaluated
for various indications. Even liver surgery was already performed
by robotics, which may add several benefits to improve standard
laparoscopic operations. The excellent three dimensional view,
use of an endowrist, three surgeon controlled arms, which result in
an excellent stable operation field enabling very precisemaneuvers
are arguments for robotic tools (5). Nevertheless, a recent inter-
national survey on technical aspects of liver surgery showed that
Germany is worldwide behind in the performance of minimally
invasive liver resections programs (6).We picked up this issue and
started as the first center in Germany minimally invasive robotic-
based liver resections. We are still in a learning curve, but the
procedure and the set up are standardized. We share here our
initial experiences in liver malignancies.
Materials and Methods
Patients and Tumors
Between June 2013 and March 2015, nine patients with malig-
nant liver tumors were operated with robotic-based minimally
invasive surgery. One of these patients suffered from intrahepatic
cholangiocellular carcinoma (CCC), four patients from hepato-
cellular carcinoma (HCC), and four patients from metachronous
colorectal liver metastases (CRC). Only patients with 2 unilat-
eral lesions identified by preoperative imaging techniques (CT-
scan, MRI) were selected. The mean tumor size was 4.4 cm
(range 3.5–5.5 cm). Two patients with CRC underwent previous
laparoscopic rectum resection, one patient robotic-based rectum
resection and one patient open rectum extirpation. One patient
with HCC was treated with laparoscopic sigmoid resection for
diverticulitis prior to liver resection. Patient demographics are
listed in Table 1.
Operative Setting
For robotic-based liver resection, we used the Da Vinci Si System
(Intuitive Surgical, Inc., CA, USA). Patients were placed in a
reverse Trendelenburg position. The screen was located at the
head end of the patient. The robot cartmoved over the right shoul-
der. The anesthesia was positioned at the left, the assisting nurse at
the right and the assisting surgeon between the legs of the patient
(Figure 1). A pneumoperitoneum was achieved puncturing the
abdomen with a veress needle in the left upper abdomen. In case
of adhesions resulting from prior surgery pneumoperitoneum
and explorative laparoscopy can be initiated via a 5mm port in
the same position. The camera of the robot was positioned right
above the umbilicus via a 10-mm trocar. If necessary, a 10-mm
trocar can be placed below the umbilicus for pringle maneuver.
To the left side of the umbilicus, a 10-mm trocar for laparoscopic
assistance was inserted. The robotic arm 1 was positioned in the
left middle abdomen, the robotic arm 2 in the right upper, and
the robotic arm 3 in the left upper abdomen (Figure 2A). Arm 3
was mainly used for liver exposure while via arm 1 and 2 a bipolar
forceps andmonopolar scissors were placed for tissue preparation
(Figure 2B). Liver parenchymal dissection was carried out with
harmonic scalpel, which can be inserted via each robotic arm
TABLE 1 |Demographic, perioperative, and histopathology data of patients, which underwent robotic-based liver resection for primary and secondary liver
malignancies.
Patient Age
(years)
Tumor Tumor
size
(cm)
R-status Surgery Operation
time (min)
Previous
abdominal
surgery
Liver fibrosis
(Ishak-scoring)
Hepatic
steatosis
Postop.
morbidity
Discharge
(postop.
day)
1 71 CCC 5:5 0 Left lateral 458 None n.d. 20–40% None 7
2 45 CRC 3:5 0 Left lateral 368 Robotic
sigmoid
0 None None 6
3 75 CRC 4:5 0 Left lateral 314 Lap. rectum 0 5% None 5
4 66 HCC 5 0 Left lateral,
gallblader
405 Open
sigmoid
2 5% None 9
5 64 HCC 3:1 0 Segment III 138 None n.d. n.d. None 6
6 58 HCC 5 0 Ablation
segment II/III
and IV
115 None 4–5 n.d. None 3
7 69 CRC 4:1 0 Left lateral 228 Open rectum
extirpation
1 5–10% Small bowel
fistula
10
8 62 HCC 5 0 Left lateral 403 None 6 20–30% None 6
9 57 CRC 3:5 0 Segment V,
gallblader
375 Lap. rectum 1 n.d. None 6
n.d., not determined.
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FIGURE 1 | Operative setting for robotic based liver surgery. * © 2015 Intuitive Surgical, Inc. All other figures are original.
needed. Via the assistant port a laparoscopic succor was placed
to reduce smoke exposure or to maintain visualization in case of
bleeding. Vessel clipping was performed by using robotic clips,
which we prefer for bigger vessels or via the assistant port with
laparoscopic clips. The portal or liver vein can be divided by a
stapler via the assistant port. Usually, we started the preparation
by defining the resection margins with laparoscopic ultrasound.
After incising the liver capsular, a shadow can be identified, this
shadow marks the distance between liver lesion and resection
margin (Figure 3). In a next step, and if necessary, the liver side
containing the tumor wasmobilized and extrahepatic vessels were
dissected. Then, the parenchyma dissection started. Intrahepatic
vessels and bile ducts were clipped or stitched. The resected
specimens were inserted in a bag and removed via a pfannenstiel
incision or in case of prior open surgery using preexisting scars
(Figure 4A). Usually, a drain was placed which was removed on
postoperative day 2. The fascia was stitched and skin incisions
were glued.
In one case (case 6, Table 1), only liver ablation could be per-
formed resulting from unexpected intrahepatic findings. In this
patient, microwave ablation was used. The needles were placed
through the trocars or percutaneously guided by ultrasound. The
liver tumors were exposed using the robotic arms to protect
neighboring tissue (Figure 4B).
Results
Perioperative Variables
Six patients had undergone prior surgery and suffered from adhe-
sions, which were less in the minimally invasive pre-operated
cases. In six patients, a left lateral resection and in two cases
a single segmental resection were performed. In two cases, the
gallbladder was removed for stones or tumor adhesion. Initially,
in one patient (case 6, Table 1) left hemihepatectomy was con-
sidered but for reasons of unexpected intraoperative identified
liver zhirrosis, which prohibited major resection, only microwave
ablation of HCC in segments II/III and IV were performed
after liver biopsy. The mean operation time was 312min (range
115–458min). A 60min preoperative time for pre-setting the
robot and 30min postoperative time for re-setting the robotic
system must be considered. The mean estimated blood loss was
251ml (range 10–650ml). No red blood cell substitution was
necessary. The mean hospital stay of the patients was 6 days
(range 3–10 days). The need for minimum hospital stay to achieve
complete reimbursement was respected if possible.
Histopathology of the Resected Specimens
In histopathology, in one case CCC, in three cases HCC, and in
four cases CRC were confirmed. The mean weight of the resected
liver specimens was 182 g (range 62–260). In all resected cases, R0
status was confirmed by histopathology. The men resection mar-
gin was 0.6 cm (range 0.1–1.5 cm). Five percent hepatic steatosis
was identified in two patients, 5–10% in one patient, and>20% in
two patients. Severe liver fibrosis (Ishak 4–6) was present in two
cases and less liver fibrosis (Ishak 1–2) in three patients. Steatosis
and severe fibrosis was mainly present in patients with primary
liver malignancies.
Morbidity and Mortality
Postoperative morbidity (30 days postoperative) occurred in
one patient. One patient (patient 7, Table 1) developed a small
intestine fistula to the camera port on postoperative day 5. The
fistula healed spontaneously under conservative treatment and
the patient was discharged on postoperative day 10. No bile leaks
occurred. Morbidity did not correlate with hepatic steatosis or
fibrosis. No postoperative mortality occurred.
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FIGURE 2 | (A) Trocar placement for robotic based minimally invasive liver
surgery, robotic trocars for arm 1-3 (A1–A3), 10mm laparoscopic trocars for
the camera (C), the surgical assistance (Ass) and if necessary pringle
maneuver (Pr). (B) Intraopeartive use of the robotic arms. Arm 1: monopolar
scissors, arm 2 bipolar forceps, both for tissue preparation, arm 3: liver
exposure. The liver tissue is protected by using a sponge. Via the assistant
port a laporoscopic succor is inserted to reduce smoke exposure.
Follow Up
During a mean follow up of 12months (range 1–21months),
two patients developed tumor recurrence. One patient (patient
1, Table 1) developed CCC recurrence in liver segments IV and
VI/VII 8months after liver resection. The initial resection margin
in this case was 1.5 cm. This patient is currently under chemother-
apy. One patient (patient 7, Table 1) developed tumor recurrence
in liver segments V and VI 4weeks after liver operation. In these
segments, no tumor was identified prior to surgery. The lesions
were ablated interventionally. No patient died during follow up.
Discussion
Our experience demonstrates that robotic-based minimally inva-
sive surgery is feasible for primary and secondary liver malignan-
cies. Complete and oncological adequate removal of the tumors
FIGURE 3 | Laparoscopic ultrasound to identify resection margin. Red
arrows indicate the tumor margin, yellow arrow indicates a shadow induced
by an incision of the liver capsular.
FIGURE 4 | (A) Robotic resected and via pfannenstiel incision removed left
lateral liver containing rectal cancer liver metastasis. (B) Robotic guided HCC
microwave ablation. The needle is placed via a 10mm laparoscopic trocar. A
sponge is used to protect the liver tissue during the exposure.
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is possible. Liver parenchymal disorders like steatosis or fibrosis
are no limitations for this technique but correlate with increased
operation time. In these cases, the identification for intrahepatic
structures is more time consuming. Even adhesions after prior
surgery are no contraindications for robotic-based procedures.
In case of expected relevant adhesions, the situation can be clar-
ified by explorative laparoscopy via a 5-mm trocar in the left
upper abdomen after inducing the pneumoperitoneum. If neces-
sary, laparoscopic mobilization of adherent tissue to the ventral
abdomen can be performed. Still operation time is longer and
blood loss slightly higher than in open procedures. But even in
series of minor resections beyond 25 cases, a mean operation time
of 4 h for conventional laparoscopic liver surgery was described
(7). Comparing larger international series, laparoscopic resections
last usually longer than comparable open procedures and in a
compared analysis between laparoscopic vs. robotic resections the
time for the robotic procedures was prolonged (2, 8). In this series,
a mean operation time of 253min with the robot and a room
covering time of 342min was described (8). This observation
was persisting even in minor resections within the study and
is in concordance with our experience that pre-setting and re-
setting of the robot covers around 90min even in an experienced
team. Generally, a mean blood loss of 250ml for laparoscopic
liver resections is described, which was within our range (2). But
for minor resections it should be much less. Comparing minor
robotic vs. laparoscopic liver resections, a mean estimated blood
loss of 285 vs. 50mlwas recently identified (8). These observations
elucidate the demand of special operation techniques for robotic
procedures. Conventional laparoscopic techniques cannot be eas-
ily transferred to the robot but must be adapted for its special
needs. But during the initiation phase of minimally invasive liver
operation the robotic-based surgery gives the surgeon a more
comfortable and safe feeling. The outstanding visualization, three
easy handling arms with precise instruments and one additional
assistant instrument in a stable operation field produce a straight
forward and controllable scenario for beginners. The liver can
be exposed very well, bleeding can be controlled and stitching
using an endowrist is muchmore easily compared to conventional
laparoscopy. Even intrahepatic structures can be well exposed
by preparing the tissue with the monopolar scissors. Neverthe-
less, the perspective of the abdomen is quite different compared
to open procedures. For this reason, it is indispensable to be
familiar with the liver anatomy. The resection margins can be
identified very well by laparoscopic ultrasound. But the resection
line must be respected during the whole operation, which might
be challenging sometimes because there is no haptic feedback
and the tumor cannot be palpated intraoperative. Furthermore,
we demonstrated that changing intraoperative strategies such as
minimally invasive guided tumor ablation is possible with the
robot.
The robot really adds helpful tools for minimally invasive
liver resections. But it cannot show its real benefits in minimally
invasive segmental resections, which can be carried out even by
conventional laparoscopy. These operations are good for starting
these procedures and overcoming a learning curve. The highly
innovative robotic technique is available and it will stay. The
real benefits of robotic based minimally invasive liver resections
should be expected in major procedures beyond minor resections
with the currently available technology. It remains the surgeons’
preference to identify adequate candidates and indications.
Ethical Guideline Statement
Informed consent was obtained from all patients and the study
was carried out in accordance with institutional and national
guidelines and regulations.
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